Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Amdocs Narrows FY2025 Adj EPS Guidance from $6.86-$7.12 to $6.96-$7.02 vs $6.97 Est; Raises FY2025 Sales Guidance from $4.459B-$4.550B to $4.505B-$4.555B vs $4.511B Est

Author: Benzinga Newsdesk | August 06, 2025 03:06pm
Amdocs (NASDAQ:DOX) narrows FY2025 Adj EPS guidance from $6.86-$7.12 to $6.96-$7.02 vs $6.97 analyst estimate. Raises FY2025 sales outlook from $4.459 billion-$4.550 billion to $4.505 billion-$4.555 billion vs $4.511 billion estimate.

Posted In: DOX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist